Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access colorectal cancer specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colorectal cancer treatment provided free
High blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whether minority groups such as Black/African American and/or Hispanic/Latino with refractory metastatic colorectal cancer (mCRC) have a bigger risk of higher blood pressure after treatment with fruquintinib. The main aim of this study is to learn how often adults of a minority group experience hypertension after they have been treated with fruquintinib f
Sponsor: Takeda
Check if you qualify for this colorectal cancer clinical trial in Tucson, AZ
If you're searching for colorectal cancer treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.